Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome

GÜZELANT, Asuman; KARAİBRAHİMOĞLU, ADNAN; CAN, Ummugulsum; buyukinan, muammer

Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome

Ummugulsum CAN, (Konya Eğitim ve Araştırma Hastanesi, Biyokimya Birimi, Konya, Türkiye)

Muammer BÜYÜKİNAN, (Konya Eğitim ve Araştırma Hastanesi, Çocuk Endokrinolojisi Anabilim Dalı, Konya, Türkiye)

Asuman GÜZELANT, (Konya Eğitim ve Araştırma Hastanesi, Mikrobiyoloji Anabilim Dalı, Konya, Türkiye)

Adnan KARAİBRAHİMOĞLU (Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Tıp Eğitimi ve Enformatik Bölümü Biyoistatistik Uzmanlığı, Konya, Türkiye)

Van Tıp Dergisi

2 1

Yıl: 2016 Cilt: 23 Sayı: 4 Sayfa Aralığı: 307 - 312 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome

Öz:

Amaç: Metabolik Sendromun primer nedeni erişkin ve çocuk popülasyonunda insülin rezistansı ile sonuçlanan düşük dereceli inflamasyon ile ilgili obezitedir. Heat şok protein 70,S100A12 ve matriks Gla protein kronik inflamatuar hastalık ile ilgilidir. Çocuk çağı obezitesi ve metabolik sendromun da bu markırları değerlendirmeyi amaçladık. Gereç ve Yöntem: Bu çalışma 10-15 yaş aralığında 45 obez çocuk ve 47 metabolik sendrom'lu çocukta yapıldı. Heat şok protein 70, S100A12 ve matriks Gla protein ELISA metodu kullanılarak ölçüldü.Bulgular: Obez çocuklarda serum matriks Gla protein ve S100A12 seviyeleri metabolik sendrom'lu gruptan anlamlı olarak yüksekti (p<0.05). İlaveten, metabolik sendrom ve obez bireyler arasında serum hsCRP (p=0.288) ve heat şok protein 70 (p=0.960) fark yoktu. Her iki grupta S100A12, matriks Gla protein ve heat şok protein 70 seviyeleri arasında anlamlı pozitif korelasyon vardı. Sonuç: Bulgularımız S100A12, matriks Gla protein ve heat şok protein 70 biyomarkırları metabolik sendrom ve obezite ile anlamlı olarak ilgili olduğunu gösterdi. Obezite metabolik sendrom gelişiminde önemli bir risk faktörüdür. Obezitede bu proteinlerin artışı, metabolik sendrom ve diabet gibi metabolik bozuklukların gelişiminin önlenmesinde ilgi çekici olabilir.

Anahtar Kelime:

Konular: Cerrahi

Çocukluk Çağı Obezite ve Metabolik Sendromda Serum Heat Şok Protein 70, S100A12 ve Matriks Gla Protein

Öz:

Objectives: The primary cause of the metabolic syndrome appears to be obesity that is associated with a low-grade inflammatory state resulting from insulin resistance in both adult and pediatric populations. Heat shock protein 70, S100A12 and matrix Gla protein are involved in chronic inflammatory diseases. We aimed to evaluate the association between these markers and childhood obesity and metabolic syndrome. Materials and Methods: This study was performed with 45 obese children aged 10-15 years and 47 children with metabolic syndrome aged 10-15 years. Serum heat shock protein 70, S100A12 and matrix Gla protein levels were measured by using ELISA method. Results: Serum matrix Gla protein and S100A12 levels in obese subjects were significantly higher than metabolic syndrome groups (p<0.05). However no significant differences were observed in serum high sensitivity Creactive protein (p=0.288) and heat shock protein 70 (p=0.960) levels between metabolic syndrome and obese subjects. There was a significant positive correlation between serum S100A12, matrix Gla protein and heat shock protein 70 levels in both groups. Conclusions: Our findings showed a significant association between heat shock protein 70, S100A12, matrix Gla protein, and obesity and metabolic syndrome. Obesity may be involved in increased risk of developing metabolic syndrome. It might be useful to focus on the roles of these proteins in obesity in accordance with the prevention of the development of metabolic syndrome and other metabolic disorders like diabetes.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

Morandi A, Maffeis C. Predictors of metabolic risk in childhood obesity. Horm Res Paediatr 2014; 82(1): 3-11.
Weiss R, Bremer AA, Lustig RH. What is metabolic syndrome, and why are children getting it? Ann N Y Acad Sci 2013; 1281: 123-140.
Lee L, Sanders RA. Metabolic syndrome. Pediatr Rev 2012; 33(10): 459-466.
Day AS, Ehn M, Gearry RB, Lemberg DA, Leach ST. Fecal S100A12 in healthy infants and children. Dis Markers 2013; 35(5): 295-299.
Nahas EA, Nahas-Neto J, Orsatti CL, Tardivo AP, Uemura G, Peraçoli MT et al. The 60- and 70-kDa heat-shock proteins and their correlation with cardiovascular risk factors in postmenopausal women with metabolic syndrome. Cell Stress Chaperones 2014; 19(4): 559-568.
Tiss A, Khadir A, Abubaker J, Abu-Farha M, Al- Khairi I, Cherian P, et al. Immunohistochemical profiling of the heat shock response in obese non-diabetic subjects revealed impaired expression of heat shock proteins in the adipose tissue. Lipids Health Dis 2014; 13: 106.
Shroff R, Dégi A, Kerti A, Kis E, Cseprekál O, Tory K, et al. Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol. 2013; 28(6): 875-884.
Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Verschuren WM, Boer JM, et al. Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients. Diabetes Care 2013; 36(11): 3766-3771.
Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F. Growth references for Turkish children aged 6 to 18 years. Acta Paediatr 2006; 95(12): 1635-1641.
Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O. Body mass index references for Turkish children. Acta Paediatr 2006; 95(2): 194- 198.
Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45(239): 13-23.
Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007; 8(5): 299-306.
Hofmann Bowman M, Wilk J, Heydemann A, Kim G, Rehman J, et al. S100A12 mediates aortic wall remodeling and aortic aneurysm. Circ Res 2010; 106(1): 145-154.
Hasegawa T, Kosaki A, Kimura T, Matsubara H, Mori Y, Okigaki M, et al. The regulation of EN- RAGE (S100A12) gene expression in human THP-1 macrophages. Atherosclerosis 2003; 171(2): 211-218.
Kosaki A, Hasegawa T, Kimura T, Iida K, Hitomi J, Matsubara H, et al. Increased plasma S100A12 (EN- RAGE) levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2004; 89(11): 5423-5428.
Mortensen OH, Nielsen AR, Erikstrup C, Plomgaard P, Fischer CP, Krogh-Madsen R, et al. Calprotectin-a novel marker of obesity. PLoS One 2009; 4(10): e7419.
Ryder E, Pedreañez A, Vargas R, Peña C, Fernandez E, Diez-Ewald M, et al.. Increased proinflammatory markers and lipoperoxidation in obese individuals: Inicial inflammatory events? Diabetes Metab Syndr 2015; 9(4): 280-286.
Simar D, Jacques A, Caillaud C. Heat shock proteins induction reduces stress kinases activation, potentially improving insulin signalling in monocytes from obese subjects. Cell Stress Chaperones 2012; 17(5): 615-621.
Armutcu F, Ataymen M, Atmaca H, Gurel A. Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin Chem LabMed 2008; 46(6): 785-790.
Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
Nishimoto SK, Nishimoto M. Matrix gla protein binds to fibronectin and enhances cell attachment and spreading on fibronectin. Int J Cell Biol 2014; 2014: 807013.
Yao Y, Watson AD, Ji S, Boström KI. Heat shock protein 70 enhances vascular bone morphogenetic protein-4 signaling by binding matrix Gla protein. Circ Res 2009; 105(6): 575- 584.

APA	CAN U, buyukinan m, GÜZELANT A, KARAİBRAHİMOĞLU A (2016). Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. , 307 - 312.
Chicago	CAN Ummugulsum,buyukinan muammer,GÜZELANT Asuman,KARAİBRAHİMOĞLU ADNAN Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. (2016): 307 - 312.
MLA	CAN Ummugulsum,buyukinan muammer,GÜZELANT Asuman,KARAİBRAHİMOĞLU ADNAN Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. , 2016, ss.307 - 312.
AMA	CAN U,buyukinan m,GÜZELANT A,KARAİBRAHİMOĞLU A Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. . 2016; 307 - 312.
Vancouver	CAN U,buyukinan m,GÜZELANT A,KARAİBRAHİMOĞLU A Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. . 2016; 307 - 312.
IEEE	CAN U,buyukinan m,GÜZELANT A,KARAİBRAHİMOĞLU A "Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome." , ss.307 - 312, 2016.
ISNAD	CAN, Ummugulsum vd. "Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome". (2016), 307-312.

APA	CAN U, buyukinan m, GÜZELANT A, KARAİBRAHİMOĞLU A (2016). Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. Van Tıp Dergisi, 23(4), 307 - 312.
Chicago	CAN Ummugulsum,buyukinan muammer,GÜZELANT Asuman,KARAİBRAHİMOĞLU ADNAN Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. Van Tıp Dergisi 23, no.4 (2016): 307 - 312.
MLA	CAN Ummugulsum,buyukinan muammer,GÜZELANT Asuman,KARAİBRAHİMOĞLU ADNAN Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. Van Tıp Dergisi, vol.23, no.4, 2016, ss.307 - 312.
AMA	CAN U,buyukinan m,GÜZELANT A,KARAİBRAHİMOĞLU A Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. Van Tıp Dergisi. 2016; 23(4): 307 - 312.
Vancouver	CAN U,buyukinan m,GÜZELANT A,KARAİBRAHİMOĞLU A Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome. Van Tıp Dergisi. 2016; 23(4): 307 - 312.
IEEE	CAN U,buyukinan m,GÜZELANT A,KARAİBRAHİMOĞLU A "Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome." Van Tıp Dergisi, 23, ss.307 - 312, 2016.
ISNAD	CAN, Ummugulsum vd. "Serum Heat Shock Protein 70, S100A12 and Matrix Gla Protein in Childhood Obesity and Metabolic Syndrome". Van Tıp Dergisi 23/4 (2016), 307-312.